🇺🇸 FDA
Patent

US 9914722

Compounds for treating spinal muscular atrophy

granted A61KA61K31/352A61P

Quick answer

US patent 9914722 (Compounds for treating spinal muscular atrophy) held by PTC THERAPEUTICS, INC. expires Mon Mar 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
PTC THERAPEUTICS, INC.
Grant date
Tue Mar 13 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K31/352, A61P, A61P21/00, A61P21/04